1. Home
  2. PCVX vs HSIC Comparison

PCVX vs HSIC Comparison

Compare PCVX & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • HSIC
  • Stock Information
  • Founded
  • PCVX 2013
  • HSIC 1932
  • Country
  • PCVX United States
  • HSIC United States
  • Employees
  • PCVX N/A
  • HSIC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • HSIC Medical Specialities
  • Sector
  • PCVX Health Care
  • HSIC Health Care
  • Exchange
  • PCVX Nasdaq
  • HSIC Nasdaq
  • Market Cap
  • PCVX 4.4B
  • HSIC 9.0B
  • IPO Year
  • PCVX 2020
  • HSIC 1995
  • Fundamental
  • Price
  • PCVX $33.25
  • HSIC $74.67
  • Analyst Decision
  • PCVX Strong Buy
  • HSIC Buy
  • Analyst Count
  • PCVX 10
  • HSIC 10
  • Target Price
  • PCVX $136.50
  • HSIC $79.30
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • HSIC 1.5M
  • Earning Date
  • PCVX 08-05-2025
  • HSIC 08-05-2025
  • Dividend Yield
  • PCVX N/A
  • HSIC N/A
  • EPS Growth
  • PCVX N/A
  • HSIC 8.11
  • EPS
  • PCVX N/A
  • HSIC 3.21
  • Revenue
  • PCVX N/A
  • HSIC $12,669,000,000.00
  • Revenue This Year
  • PCVX N/A
  • HSIC $4.28
  • Revenue Next Year
  • PCVX N/A
  • HSIC $3.57
  • P/E Ratio
  • PCVX N/A
  • HSIC $23.27
  • Revenue Growth
  • PCVX N/A
  • HSIC 1.75
  • 52 Week Low
  • PCVX $27.66
  • HSIC $60.56
  • 52 Week High
  • PCVX $121.06
  • HSIC $82.49
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 45.61
  • HSIC 68.83
  • Support Level
  • PCVX $32.00
  • HSIC $72.21
  • Resistance Level
  • PCVX $34.63
  • HSIC $75.34
  • Average True Range (ATR)
  • PCVX 1.33
  • HSIC 1.30
  • MACD
  • PCVX -0.06
  • HSIC 0.25
  • Stochastic Oscillator
  • PCVX 33.67
  • HSIC 88.35

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: